Max Müller becomes the new TeleClinic CEO
28.03.2022 12:26
Katharina Jünger, founder and CEO of TeleClinic GmbH, is leaving the company at her own request on April 1, 2022 in order to take on new professional challenges after her parental leave. Long-time co-managing director Max Müller will take over your tasks and functions.
Since 2015, Katharina Jünger has built TeleClinic, one of the leading platforms for online doctor visits in Germany. After the change of ownership in July 2020, she led the successful integration of TeleClinic into the Zur Rose Group. With high quality standards, TeleClinic has now established itself as the first point of contact for digital health among doctors and patients. Doctors based in Germany treat tens of thousands of patients on the platform every month, and the company continues to grow. TeleClinic has played a key role in shaping the digital health market in Germany under its previous management duo. Particularly during the corona pandemic, telemedicine makes an important social contribution to ensuring comprehensive health care. Patients can visit a doctor online via video and receive prescriptions and sick notes.
Walter Hess, Head Germany of the Zur Rose Group, says: “With great commitment and personal commitment, Katharina Jünger has built up TeleClinic as a pioneer and leading provider of telemedical services in Germany and thus actively pushed forward the digitalization of the healthcare system. On behalf of the Board of Directors, I would like to thank her for the successful time we spent together and wish her much success and all the best personally in her plans to build many more strong companies.”
Max Müller will succeed Katharina Jünger. As co-managing director and COO of TeleClinic, Max Müller is very familiar with the operational telemedicine business and strategic corporate projects as well as the opportunities and challenges of digitalization in Germany. Walter Hess emphasizes: “As COO, Max Müller built TeleClinic into a rapidly growing telemedicine provider. He has profound marketing and product expertise and, as future CEO, will lead TeleClinic into the next development phase within the Zur Rose Group.”